SPECC1 and viral infectious disease: Lopinavir and ritonavir-HIV protease inhibitor, is a combination antiviral medicine used to treat HIV[34], which could inhibit SARS-CoV and MERS-CoV infection in vitro, and they may target SARS-CoV-2 Nsp5 (3CLpro) to inhibit virus infection.